In the Canadian medical devices industry, there were five M&A deals announced in Q3 2024, worth a total value of $1bn, according to GlobalData’s Deals Database. The $984.2m acquisition of LifeLabs by Quest Diagnostics was the industry’s largest disclosed deal. GlobalData’s ³Ô¹ÏºÚÁÏÍøs Industry Mergers and Acquisitions Deals by Top Themes in Q3 2024 report helps understand the pivotal themes steering M&A activity in the industry.
In value terms, M&A activity in Canada increased by 11264% in Q3 2024 compared with the previous quarter’s total of $8.8m. Related deal volume decreased by 17% in Q3 2024 versus the previous quarter and was 150% higher than in Q3 2023.
The top-ranked financial advisors supporting these M&A deals in Canada in 9M 2024 were Canadian Imperial Bank of Commerce; Clairfield International; Evercore with 1, 1, 1 deals respectively.
The top-ranked legal advisors supporting these M&A deals in Canada in 9M 2024 were John Wood Group; McCarthy Tetrault; Mintz, Levin, Cohn, Ferris, Glovsky and Popeo PC with 1, 1, 1 deals respectively.
For further understanding of GlobalData's ³Ô¹ÏºÚÁÏÍøs Industry Mergers And Acquisitions Deals By Top Themes In Q3 2024 – Strategic Intelligence,
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.